These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 16495798

  • 1. Liver allocation for hepatocellular carcinoma: a European Center policy in the pre-MELD era.
    Ravaioli M, Grazi GL, Ercolani G, Cescon M, Del Gaudio M, Zanello M, Ballardini G, Varotti G, Vetrone G, Tuci F, Lauro A, Ramacciato G, Pinna AD.
    Transplantation; 2006 Feb 27; 81(4):525-30. PubMed ID: 16495798
    [Abstract] [Full Text] [Related]

  • 2. A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system.
    Piscaglia F, Camaggi V, Ravaioli M, Grazi GL, Zanello M, Leoni S, Ballardini G, Cavrini G, Pinna AD, Bolondi L.
    Liver Transpl; 2007 Jun 27; 13(6):857-66. PubMed ID: 17539006
    [Abstract] [Full Text] [Related]

  • 3. Survival benefit after liver transplantation: a single European center experience.
    Ravaioli M, Grazi GL, Dazzi A, Bertuzzo V, Ercolani G, Cescon M, Cucchetti A, Masetti M, Ramacciato G, Pinna AD.
    Transplantation; 2009 Sep 27; 88(6):826-34. PubMed ID: 19920783
    [Abstract] [Full Text] [Related]

  • 4. Liver transplantation for hepatocellular carcinoma: the MELD impact.
    Sharma P, Balan V, Hernandez JL, Harper AM, Edwards EB, Rodriguez-Luna H, Byrne T, Vargas HE, Mulligan D, Rakela J, Wiesner RH.
    Liver Transpl; 2004 Jan 27; 10(1):36-41. PubMed ID: 14755775
    [Abstract] [Full Text] [Related]

  • 5. Liver transplantation for hepatocellular carcinoma: lessons from the first year under the Model of End-Stage Liver Disease (MELD) organ allocation policy.
    Yao FY, Bass NM, Ascher NL, Roberts JP.
    Liver Transpl; 2004 May 27; 10(5):621-30. PubMed ID: 15108253
    [Abstract] [Full Text] [Related]

  • 6. Comparison of clinical outcomes in chronic hepatitis B liver transplant candidates with and without hepatocellular carcinoma.
    Wong SN, Reddy KR, Keeffe EB, Han SH, Gaglio PJ, Perrillo RP, Tran TT, Pruett TL, Lok AS.
    Liver Transpl; 2007 Mar 27; 13(3):334-42. PubMed ID: 17154401
    [Abstract] [Full Text] [Related]

  • 7. A decade of right liver adult-to-adult living donor liver transplantation: the recipient mid-term outcomes.
    Chan SC, Fan ST, Lo CM, Liu CL, Wei WI, Chik BH, Wong J.
    Ann Surg; 2008 Sep 27; 248(3):411-9. PubMed ID: 18791361
    [Abstract] [Full Text] [Related]

  • 8. Model for End-Stage Liver Disease (MELD) system to allocate and to share livers: experience of two Italian centers.
    Ravaioli M, Masetti M, Dazzi A, Romano A, Spaggiari M, Grazi GL, Ercolani G, Cescon M, Di Gioia P, De Ruvo N, Montalti R, Ballarin R, Di Benedetto F, Ridolfi L, Alvaro N, Ramacciato G, Morelli C, Gerunda E, Pinna AD.
    Transplant Proc; 2008 Sep 27; 40(6):1814-5. PubMed ID: 18675057
    [Abstract] [Full Text] [Related]

  • 9. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
    Yi NJ, Suh KS, Lee HW, Shin WY, Kim J, Kim W, Kim YJ, Yoon JH, Lee HS, Lee KU.
    Liver Transpl; 2009 May 27; 15(5):496-503. PubMed ID: 19399732
    [Abstract] [Full Text] [Related]

  • 10. Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system?
    Cuomo O, Perrella A, Arenga G.
    Transplant Proc; 2008 May 27; 40(6):1906-9. PubMed ID: 18675085
    [Abstract] [Full Text] [Related]

  • 11. Liver transplantation for childhood hepatic malignancy: a review of the United Network for Organ Sharing (UNOS) database.
    Austin MT, Leys CM, Feurer ID, Lovvorn HN, O'Neill JA, Pinson CW, Pietsch JB.
    J Pediatr Surg; 2006 Jan 27; 41(1):182-6. PubMed ID: 16410130
    [Abstract] [Full Text] [Related]

  • 12. Survival after liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease and pre-model for end-stage liver disease eras and the independent impact of hepatitis C virus.
    Thuluvath PJ, Maheshwari A, Thuluvath NP, Nguyen GC, Segev DL.
    Liver Transpl; 2009 Jul 27; 15(7):754-62. PubMed ID: 19562709
    [Abstract] [Full Text] [Related]

  • 13. Outcome of patients with hepatocellular carcinoma listed for liver transplantation within the Eurotransplant allocation system.
    Adler M, De Pauw F, Vereerstraeten P, Fancello A, Lerut J, Starkel P, Van Vlierberghe H, Troisi R, Donckier V, Detry O, Delwaide J, Michielsen P, Chapelle T, Pirenne J, Nevens F.
    Liver Transpl; 2008 Apr 27; 14(4):526-33. PubMed ID: 18383082
    [Abstract] [Full Text] [Related]

  • 14. Validation of the HCC-MELD for dropout probability in patients with small hepatocellular carcinoma undergoing locoregional therapy.
    Huo TI, Huang YH, Su CW, Lin HC, Chiang JH, Chiou YY, Huo SC, Lee PC, Lee SD.
    Clin Transplant; 2008 Apr 27; 22(4):469-75. PubMed ID: 18318736
    [Abstract] [Full Text] [Related]

  • 15. Liver transplantation in the United States.
    Qiu J, Ozawa M, Terasaki PI.
    Clin Transpl; 2005 Apr 27; ():17-28. PubMed ID: 17424722
    [Abstract] [Full Text] [Related]

  • 16. Superiority of transplantation versus resection for the treatment of small hepatocellular carcinoma.
    Baccarani U, Isola M, Adani GL, Benzoni E, Avellini C, Lorenzin D, Bresadola F, Uzzau A, Risaliti A, Beltrami AP, Soldano F, De Anna D, Bresadola V.
    Transpl Int; 2008 Mar 27; 21(3):247-54. PubMed ID: 18028264
    [Abstract] [Full Text] [Related]

  • 17. Model for End-Stage Liver Disease (MELD) score and organ allocation from cadaveric donors for 198 liver transplantation procedures performed in a single center.
    Santori G, Andorno E, Morelli N, Casaccia M, Bottino G, Ghirelli R, Valente U.
    Transplant Proc; 2008 Mar 27; 40(6):1903-5. PubMed ID: 18675084
    [Abstract] [Full Text] [Related]

  • 18. Liver transplantation for hepatocellular carcinoma in New Zealand: a prospective intent-to-treat analysis.
    Marui Y, McCall J, Gane E, Holden A, Duncan D, Yeong ML, Chow K, Munn S.
    N Z Med J; 2005 Jun 24; 118(1217):U1532. PubMed ID: 15980906
    [Abstract] [Full Text] [Related]

  • 19. Impact of pretransplant diagnosis of hepatocellular carcinoma on cadveric liver allocation in the era of MELD.
    Hayashi PH, Trotter JF, Forman L, Kugelmas M, Steinberg T, Russ P, Wachs M, Bak T, Kam I, Everson GT.
    Liver Transpl; 2004 Jan 24; 10(1):42-8. PubMed ID: 14755776
    [Abstract] [Full Text] [Related]

  • 20. Impact of model for end-stage liver disease on patient survival and disease-free survival in patients receiving liver transplantation for hepatocellular carcinoma.
    Moonka D, Castillo E, Kumer S, Abouljoud M, Divine G, Pelletier S.
    Transplant Proc; 2009 Jan 24; 41(1):216-8. PubMed ID: 19249517
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.